Atomo Diagnostics' multi-award winning AtomoRapid™ HIV last night was
awarded Best in Show, and the winner of the In Vitro Diagnostics
Category, at the 17th Medical Design Excellence Awards
(MDEA), held in New York.
Atomo Diagnostics' AtomoRapid™ blood test device scoops Best in Show at the Medical Design Excellence Awards 2014 (Photo: Business Wire)
is the medtech industry's premier design competition committed to
searching worldwide for the highest caliber finished medical devices,
products, systems, or packaging available on the market.
Atomo Diagnostics Founder & CEO John Kelly paid tribute to his daughter
whose successful battle with a childhood illness was the inspiration
behind developing a rapid POC or home-use blood test device.
The AtomoRapid™ blood testing platform can accommodate test strips for a
wide variety of conditions from celiac disease, allergy through to
infectious diseases such as malaria and HIV.
The device delivers better clinical outcomes for patients and health
care providers by enabling simpler, safer and more accurate testing in
the field or at home.
(See product images here http://atomodiagnostics.com/latest-news/gallery/)
Atomo Diagnostics Founder & CEO John Kelly said: "Our company is
delighted to get such global recognition for AtomoRapid™, a
ground-breaking and revolutionary rapid diagnostic testing platform. We
would like to thank the MDEA judges for selecting us for both these
prestigious awards, our team around the globe, and our design partner,
IDE for its excellent work in helping to bring this technology to market.
"We can now officially say we are best in the world," said the
Australian AtomoRapid™ team as they celebrated the awards.
Given its ease of use and simplicity, AtomoRapid™ HIV has the ability to
materially improve both the uptake and reliability of HIV testing in the
community and at home and we are committed to getting the product
launched in the US and Europe. AtomoRapid™ HIV is currently available
for sale in several African countries from our South Africa office.
One of the 12 industry leader MDEA 214 judges George L. Walls, director
of product and market development for ZOLL, said of AtomoRapid™:
"The AtomoRapid™ HIV hits on all cylinders: a real problem creatively
and disruptively addressed. Fast, low cost, accurate, and fundamentally
changing the use and business model in this important space. It's EPT
for HIV. "
"Clinical performance of standard test kits are proven in the lab, but
serious concerns have been raised about in-field performance. This is
down to their complex nature, requiring multiple components for the
procedure offering resulting in errors, which in turn creates false
diagnosis. For a disease such as HIV, this can have significant impact
not only on the individual, but the community too," said John Kelly.
Atomo Diagnostics www.atomodiagnostics.com
The company is actively seeking partners for market entry into the US
Product images: http://atomodiagnostics.com/latest-news/gallery/
Product in use video: http://atomodiagnostics.com/latest-news/video/
MDEA Program http://www.mddionline.com/
Photos/Multimedia Gallery Available: http://www.businesswire.com/multimedia/home/20140611006631/en/
[ Back To NFVZone's Homepage ]